Stock screener

OTLK

Conviction 14HealthcareScan · Tue, Sep 8, 2026
OTLK$0.6363-4.53%
ResistanceSupportVol 14Insider buy
63 bars
4
2
Vol MA14 9.19M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
WSB mentions · 24h changelatest +100.00%· 2 mentions
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Outlook Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.outlooktherapeutics.com ↗
Price0.6363
Change-4.53%
Gap-2.48%
Rel volume0.31×
Avg volume22.58M
Avg $ vol16.72M
SMA 200.7127
SMA 501.08
SMA 2000.8583
Price vs 50-40.93%
Price vs 200-25.87%
MA stackmixed
50/200 cross—
Supertrenddown · 0.8613
RSI (14)36
MACD hist0.02
MACD crossbull · 4d
Stoch %K / %D36 / 41
ADX (14)19
+DI / −DI21 / 27
RSI divergence—
MACD divergence—
ATR %+13.71%
ADR %9.01%
52w high2.47
52w low0.1981
From 52w high-74.24%
Above 52w low+221.20%
New 52w highNo
SqueezeOff
Bollinger width82.54%
%B0.37
Donchian pos7.85%
Donchian high1.18
Donchian low0.5900
AVWAP (52w high)0.8159
vs AVWAP high-22.01%
AVWAP (52w low)0.8094
vs AVWAP low-21.39%
OBV trendDown
Chaikin MF (20)-0.09
Today vs 20d0.31×
Avg vol (14d)9.19M
Avg vol (20d)22.58M
Avg $ vol (20d)16.72M
Market cap154.91M
RS 3m (vs SPY)-18.61%
RS 6m (vs SPY)+46.44%
RS line new highNo
Trend template1/8
Technical rank34.7
1 week+0.46%
1 month-37.62%
3 months-11.87%
6 months+42.16%
1 year-31.95%
YTD-3.59%
P/E-2.48
P/B-14.91
P/S109.59
P/FCF-2.96
EPS-1.79
Div yield—
ROE600.67%
ROA-238.40%
Debt/Eq-93.05
Current0.81
EV/EBITDA-16.62
Gross margin4.05%
Net margin—
Rev growth—
EPS growth17.17%
Price target5.20
Target upside717.22%
Analyst ratingBuy
Institutional8.91%
Ent. value1.11B
Revenue1.51M
Net income-20.32M
Gross profit-8.27K
Free cash flow-52.27M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out140.05M
Employees17
ListedFri, May 13, 2016
Free float83M
Float %99.9%
Short interest19.9M
Days to cover0.8d
Short volume55.4%
Squeeze score54 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.09 vs −$0.09
Last surprise0.0% beat
Setup gradeD
Conviction14 / 100
Pattern quality—
Tech rank34.7 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.47
Support0.5960
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OTLK

All disclosures →
No recent disclosed trades by Congress in OTLK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OTLK · 9 buys · 1 sell

InsiderSideShares
Lundquist Kevin Michael
Chief Financial Officer · Employee Stock Option (Right to Buy) · 2026-09-01
Grant500K
Jahr Robert Charles
Chief Executive Officer · Warrants (right to buy) · 2026-08-14
Buy151.51K
KENYON LAWRENCE A
Chief Financial Officer · Common Stock · 2026-08-14
Buy101.01K
KENYON LAWRENCE A
Chief Financial Officer · Warrants (right to buy) · 2026-08-14
Buy101.01K
Jahr Robert Charles
Chief Executive Officer · Common Stock · 2026-08-14
Buy151.51K
Sukhtian Ghiath M.
Director · Common Stock · 2026-08-12
Buy2.53M
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-08-12
Buy2.53M
Haddadin Yezan Munther
Director · Common Stock · 2026-06-02
Buy29K
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-05-28
Buy8.57M
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-05-28
Dispose3.46M

SEC filings

EDGAR filings in OTLK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.